Reply to ‘Skin cancer, photoprotection, and skin of color’ - 14/08/14
Doi : 10.1016/j.jaad.2014.05.027
Henry W. Lim, MD a, Oma N. Agbai, MD b, Reva Bhushan, PhD c, ⁎ 
, Kesha J. Buster, MD d, Miguel R. Sanchez, MD e, Claudia Hernandez, MD f, Roopal V. Kundu, MD g, Melvin Chiu, MD h, Wendy E. Roberts, MD i, Zoe D. Draelos, MD j, Susan C. Taylor, MD k
, Kesha J. Buster, MD d, Miguel R. Sanchez, MD e, Claudia Hernandez, MD f, Roopal V. Kundu, MD g, Melvin Chiu, MD h, Wendy E. Roberts, MD i, Zoe D. Draelos, MD j, Susan C. Taylor, MD k a Henry Ford Hospital, Detroit, Michigan
b University of California, Davis, California
c American Academy of Dermatology, Schaumburg, Illinois
d Via Christi Clinic, Wichita, Kansas
e New York University Medical Center, New York, New York
f University of Illinois College of Medicine, Chicago, Illinois
g Northwestern Center for Ethnic Skin, Northwestern University Feinberg School of Medicine, Chicago, Illinois
h University of California Los Angeles Medical Center Geffen School of Medicine, University of California, Los Angeles, California
i Desert Dermatology Rancho Mirage, California
j Dermatology Consulting Services, High Point, North Carolina
k Society Hill Dermatology and Cosmetic Center, Philadelphia, Pennsylvania
∗Correspondence to: Reva Bhushan, PhD, American Academy of Dermatology, Shaumburg, IL 60173
Le texte complet de cet article est disponible en PDF.
| Funding Sources: None. |
|
| Disclosures: Dr Roberts serves as a consultant for Allergan Medical, L'oreal, La Roche-Posay, and NeoStrata, for which she receives honoraria. She also sits on the advisory board and consults for SkinMedica, for which she receives honoraria. She receives stock options from TopMD. She consults for Theraplex, for which she receives no compensation. In 2013, Dr Taylor held seats on the advisory boards of Allergan, Beiersdorf Inc, Excaliard Pharmaceuticals, and Unilever, for which she received honoraria. She serves as a consultant for Curel Skincare, Pfizer, Schlesinger Associates, and Viviscal. Dr Taylor founded T2 Skincare, for which she receives other financial benefit and serves in other roles. She receives grants as an investigator for Hisamitsu Pharmaceutical, Medicis Pharmaceuticals, Noven Pharmaceuticals, and Pfizer. Dr Taylor has received honoraria as a speaker from Allergan, Johnson & Johnson, Kao USA, Merz Pharmaceuticals, and Neostrata. Dr Lim serves as a consultant for Ferndale and La Roche-Posay, for which he receives honoraria. All other doctors have no conflicts of interest to declare. |
© 2014
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 71 - N° 3
P. 587-588 - septembre 2014 Retour au numéro
Article précédent
- Skin cancer, photoprotection, and skin of color
- Ophelia E. Dadzie, Nina G. Jablonski, Meera Mahalingam, Alain Dupuy, Antoine Petit
- Psoriasis or obesity is a risk factor for nonalcoholic fatty liver disease
- Ploysyne Rattanakaemakorn, Alan B. Fleischer
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?